Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Taubert

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Life (Basel, Switzerland)|July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder CancerDanijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
Journal of Nanobiotechnology|November 24, 2020
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanomaManfred Kunz, Madeleine Brandl, Animesh Bhattacharya, et al.
International Journal of Molecular Sciences|January 19, 2019
Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell CarcinomaAlexander W Eckert, Susanne Horter, Daniel Bethmann, et al.
Cancer Research|May 19, 2006
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent mannerGareth L Bond, Kim M Hirshfield, Tomas Kirchhoff, et al.
Cancers|May 21, 2020
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node StageMarkus Eckstein, Elena Epple, Rudolf Jung, et al.
Cancers|September 19, 2020
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer PatientsPaul König, Markus Eckstein, Rudolf Jung, et al.
Life (Basel, Switzerland)|May 28, 2022
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer PatientsAlexander Fichte, Angela Neumann, Katrin Weigelt, et al.
Cells|January 20, 2021
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant ChemotherapyHelge Taubert, Markus Eckstein, Elena Epple, et al.
Cells|August 7, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer PatientsMarkus Eckstein, Verena Lieb, Rudolf Jung, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Life (Basel, Switzerland)|July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder CancerDanijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
Journal of Nanobiotechnology|November 24, 2020
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanomaManfred Kunz, Madeleine Brandl, Animesh Bhattacharya, et al.
International Journal of Molecular Sciences|January 19, 2019
Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell CarcinomaAlexander W Eckert, Susanne Horter, Daniel Bethmann, et al.
Cancer Research|May 19, 2006
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent mannerGareth L Bond, Kim M Hirshfield, Tomas Kirchhoff, et al.
Cancers|May 21, 2020
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node StageMarkus Eckstein, Elena Epple, Rudolf Jung, et al.
Cancers|September 19, 2020
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer PatientsPaul König, Markus Eckstein, Rudolf Jung, et al.
Life (Basel, Switzerland)|May 28, 2022
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer PatientsAlexander Fichte, Angela Neumann, Katrin Weigelt, et al.
Cells|January 20, 2021
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant ChemotherapyHelge Taubert, Markus Eckstein, Elena Epple, et al.
Cells|August 7, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer PatientsMarkus Eckstein, Verena Lieb, Rudolf Jung, et al.
Pageof 17